In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 453-20-3, name is 3-Hydroxytetrahydrofuran, introducing its new discovery. Product Details of 453-20-3
Fused tricyclic compounds and their use in medicine (by machine translation)
The invention relates to a fused tricyclic compound and an application, of the fused tricyclic compound in medicines, in particular/a pharmaceutically acceptable salt or a prodrug. of the compound shown in the formula, or a stereoisomer (I) tautomer, nitrogen oxide, solvate, of the compound shown in the general formula, or a prodrug thereof . The invention further relates to the use of the compound shown in the general formula shown (I) in the specification or a prodrug thereof, as a, drug, in, the specification. The present invention also relates to the use of the compound, represented by the general formula/shown in the specification as a medicine, or a prodrug thereof. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 453-20-3, and how the biochemistry of the body works.Product Details of 453-20-3
Reference£º
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem